Patent details

EP3478719 Title: USE OF ANTI-SCLEROSTIN ANTIBODIES IN THE TREATMENT OF OSTEOGENESIS IMPERFECTA

Basic Information

Publication number:
EP3478719
PCT Application Number:
GB2017053850
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP178231908
PCT Publication Number:
WO2018115880
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF ANTI-SCLEROSTIN ANTIBODIES IN THE TREATMENT OF OSTEOGENESIS IMPERFECTA
French Title of Invention:
UTILISATION D'ANTICORPS ANTI-SCLÉROSTINE DANS LE TRAITEMENT DE L'OSTÉOGENÈSE IMPARFAITE
German Title of Invention:
VERWENDUNG VON ANTI-SCLEROSTIN-ANTIKÖRPERN BEI DER BEHANDLUNG VON OSTEOGENESIS IMPERFECTA
SPC Number:

Dates

Filing date:
21/12/2017
Grant date:
20/01/2021
EP Publication Date:
08/05/2019
PCT Publication Date:
28/06/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
20/01/2021
EP B1 Publication Date:
20/01/2021
EP B2 Publication Date:
EP B3 Publication Date:
18/12/2024
Lapsed date:
Expiration date:
21/12/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
11/12/2024
 
 

Name:
Mereo Biopharma 3 Limited
Address:
4th Floor 1 Cavendish Place, London W1G 0QF, United Kingdom (GB)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
21/01/2021
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
RIGGS, Matthew Manning
Address:
United States (US)

2

Name:
EUDY, Rena Joy
Address:
United States (US)

3

Name:
JUNKER, Uwe
Address:
Switzerland (CH)

4

Name:
HALL, Anthony Kent
Address:
Netherlands (NL)

5

Name:
KNEISSEL, Michaela
Address:
Switzerland (CH)

Priority

Priority Number:
201662437353 P
Priority Date:
21/12/2016
Priority Country:
United States (US)

Classification

IPC classification:
C07K 16/22; A61K 39/395; A61P 19/08; A61K 39/00;

Publication

European Patent Bulletin

1

Issue number:
202103
Publication date:
20/01/2021
Description:
Grant (B1)

2

Issue number:
202425
Publication date:
19/06/2024
Description:
Request for limitation Filed (Art.105a)

3

Issue number:
202448
Publication date:
27/11/2024
Description:
Request for limitation of patent allowed

4

Issue number:
202451
Publication date:
18/12/2024
Description:
Limited Patent Specification (B3)

5

Issue number:
202108
Publication date:
24/02/2021
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
31/12/2025
Annual Fee Number:
9
Annual Fee Amount:
115 Euro
Expected Payer:
Last Annual Fee Payment Date:
13/12/2024
Last Annual Fee Paid Number:
8
Last Annual Fee Paid Amount:
99 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
29/01/2021 Outgoing Correspondence 1
21/01/2021 Power Of Attorney 1